Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual total long term liabilities is $0.00, unchanged on December 31, 2023.
- During the last 3 years, RLMD annual total long term liabilities has risen by $0.00 (0.00%).
- RLMD annual total long term liabilities is now -100.00% below its all-time high of $2.66 million, reached on June 30, 2018.
Performance
RLMD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$12.60 K
+$12.60 K+100.00%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly total long term liabilities is $12.60 thousand, with the most recent change of +$12.60 thousand (+100.00%) on September 30, 2024.
- Over the past year, RLMD quarterly long term liabilities has increased by +$12.60 thousand (+100.00%).
- RLMD quarterly long term liabilities is now -99.61% below its all-time high of $3.19 million, reached on September 30, 2018.
Performance
RLMD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RLMD Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | +100.0% |
| 3 y3 years | 0.0% | +100.0% |
| 5 y5 years | 0.0% | +100.0% |
RLMD Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -100.0% |
| 5 y | 5-year | at high | at low | at high | -100.0% |
| alltime | all time | -100.0% | at low | -99.6% | -100.0% |
Relmada Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.60 K(>+9900.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | - |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | $0.00 | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $3.19 M(+20.2%) |
| Jun 2018 | $2.66 M(>+9900.0%) | $2.66 M(+68.5%) |
| Mar 2018 | - | $1.58 M(+23.4%) |
| Dec 2017 | - | $1.28 M(+88.2%) |
| Sep 2017 | - | $678.90 K(>+9900.0%) |
| Jun 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2017 | - | $139.40 K(+1.7%) |
| Dec 2016 | - | $137.10 K(+1.8%) |
| Sep 2016 | - | $134.70 K(-4.4%) |
| Jun 2016 | $140.90 K(>+9900.0%) | $140.90 K(+29.3%) |
| Mar 2016 | - | $109.00 K(+98.9%) |
| Dec 2015 | - | $54.80 K(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2015 | - | $100.00 K(0.0%) |
| Dec 2014 | - | $100.00 K(0.0%) |
| Sep 2014 | - | $100.00 K(>+9900.0%) |
| Jun 2014 | $100.00 K(>+9900.0%) | - |
| Feb 2014 | - | $0.00(0.0%) |
| Nov 2013 | - | $0.00(0.0%) |
| Aug 2013 | $0.00(0.0%) | $0.00(0.0%) |
| May 2013 | - | $0.00(0.0%) |
| Feb 2013 | - | $0.00(0.0%) |
| Aug 2012 | $0.00 | $0.00 |
FAQ
- What is Relmada Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Relmada Therapeutics?
- What is Relmada Therapeutics annual total long term liabilities year-on-year change?
- What is Relmada Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly long term liabilities year-on-year change?
What is Relmada Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RLMD is $0.00
What is the all time high annual total long term liabilities for Relmada Therapeutics?
Relmada Therapeutics all-time high annual total long term liabilities is $2.66 M
What is Relmada Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RLMD annual total long term liabilities has changed by $0.00 (0.00%)
What is Relmada Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RLMD is $12.60 K
What is the all time high quarterly long term liabilities for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly total long term liabilities is $3.19 M
What is Relmada Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RLMD quarterly total long term liabilities has changed by +$12.60 K (+100.00%)